Photo via CBS News

Abbott Labs to pay nearly $385M in case over bacterial contamination at plant

Read the original at CBS News ↗
Cite

Lynch, S. N. (2026, September 14). Abbott Labs to pay nearly $385M in case over bacterial contamination at plant. CBS News. https://www.cbsnews.com/news/baby-formula-abbott-labs-civil-case-michigan-plant/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

CBS News · collected 2026-09-14 · by Sarah N. Lynch

Quick Summary

Abbott Laboratories agreed to pay nearly $385 million to settle a civil False Claims Act case with the Justice Department and several states regarding bacterial contamination at its Michigan baby formula plant. The settlement, announced on Monday, resolves allegations that Abbott caused government programs to purchase powdered infant formula made in unsanitary conditions, potentially endangering infants' health. Despite federal prosecutors initially supporting felony charges, senior DOJ leadership opted for a civil resolution, citing accountability and public protection as primary goals.
Written by AI on 2026-09-14, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

Abbott Laboratories, a major baby formula manufacturer, agreed to pay $385 million to settle civil False Claims Act cases with the U.S. Justice Department and several states over bacterial contamination at its largest plant in Sturgis, Michigan. The settlement resolves claims that powdered infant formula made at this facility was contaminated with Cronobacter bacteria during manufacturing, posing a risk to public health. This case followed a 2022 recall of Abbott's products after four infants fell ill from consuming the formula manufactured there. The Justice Department initially sought felony charges but later opted for a civil resolution under pressure from senior leadership. Despite this settlement, Abbott maintains it did not admit liability or fault and emphasizes no unopened distributed product tested positive for bacteria. The plant closure exacerbated existing supply shortages caused by disruptions during the COVID-19 pandemic.

Written for “Abbott Formula Settlement” on 2026-11-20, grounded in this article and the 4 other(s) covering the same event.

How they differ

5 outlets covered “Abbott Formula Settlement”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

CBS NewsThis outlet14 Sep

Abbott Laboratories agreed to pay nearly $385 million to settle a civil False Claims Act case with the Justice Department and several states regarding bacterial contamination at its Michigan baby formula plant. The settlement, announced on Monday, resolves allegations that Abbott caused government programs to purchase powdered infant formula made in unsanitary conditions, potentially endangering infants' health…

Abbott Labs to pay nearly $385M in case over bacterial contamination at plant (this article)
ABC News (US)14 Sep

Abbott Laboratories has agreed to a $385 million settlement with the Justice Department over issues related to its Michigan baby formula factory, which closed due to contamination concerns in early 2022. This closure exacerbated existing supply shortages caused by pandemic-related disruptions. The company maintains it did not admit fault or liability and highlights that tests of unopened products found no harmful…

Abbott agrees to settlement over closure of largest baby formula plant in the US →
Toronto Star14 Sep

Abbott Laboratories has agreed to settle for $385 million regarding the closure of its Sturgis, Michigan baby formula plant in 2022 due to contamination issues. This settlement resolves claims brought by the Justice Department following a federal investigation into the factory, which led to nationwide shortages of powdered infant formula.

Abbott agrees to settlement over closure of largest baby formula plant in the US →
UPI15 Sep

Abbott Laboratories agreed to pay $385 million to resolve federal allegations related to the contamination at its Sturgis, Michigan infant formula plant in 2022. The settlement addresses claims under the False Claims Act without admitting fault. Four infants fell ill and two died after consuming contaminated formula from the facility, which was closed due to safety violations including roof leaks and malfunctioning…

Abbott to pay $385M over infant formula contamination probe →
The Independent15 Sep

Abbott Laboratories has agreed to pay $385 million to settle legal claims related to a 2022 baby formula shortage caused by a recall at its Sturgis, Michigan plant. The Justice Department initiated a lawsuit amid concerns over bacterial contamination, leading to a nationwide recall of Abbott's major infant formula brands like Similac and exacerbating existing supply chain issues. While the settlement does not admit…

Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant →

Where they agree and split

Framing

How the first headlines put it

Stated as fact5
The headlines (5)

Abbott Labs to pay nearly $385M in case over bacterial contamination at plant CBS News · stated as fact

Abbott agrees to settlement over closure of largest baby formula plant in the US ABC News · stated as fact

Abbott agrees to settlement over closure of largest baby formula plant in the US Toronto Star · stated as fact

Abbott to pay $385M over infant formula contamination probe UPI · stated as fact

Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant The Independent · stated as fact

The full story: what happened, how it changed, and all 5 articles →

Compared with similar articles

This article reads unscored and hedges 29% of its claims. Each row says how that neighbour differs.
Toronto Star
Hedges 1 of 2 claims Outlet record 64/100
UPI
Hedges 4 of 13 claims Outlet record 56/100
The Independent
Centre Hedges 1 of 8 claims Outlet record 59/100
ABC News (US)
Leans left Hedges 1 of 9 claims Outlet record 67/100

Story

Abbott Formula Settlement
Economy/Business · 5 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
14
sentences that state something as happening or true
Uncertain
29%
4 of 14 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
67/100
CBS News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
5
Economy/Business
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-14 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

CBS News · 5890 article(s) · 10 correction(s) detected
Running correction rate · 10 correction(s)

Who wrote this

Sarah N. Lynch
40 article(s) here · 1 carrying a prediction
On Oct. 1, he wrote, "After months of 'Luigi' tactics (delay, deny, defend) by the HOA, we were finally able to submit an independent engineering report into the record," and said he would share the engineering report on X "when the time is right."
But before he could finish his address, he abruptly left, saying he was getting a call from the president.
The Civil Division has also had to contend with a this year from detained immigrants, after a Justice Department-run immigration court made a sweeping determination that the government could essentially detain a large swath of immigrants indefinitely while their removal proceedings are pending.
Her memo broadened the scope of the kinds of crimes that might be pursued as domestic terrorism cases, such as doxxing members of law enforcement or parading with the intent to obstruct the administration of justice.
However, they later admitted in court that the Justice Department intended to share the information with the Department of Homeland Security so they could use it for criminal and immigration enforcement purposes.
The subpoenas are the latest effort by the Justice Department to pressure California to set aside some 20,000 ballots that it claims were mailed to ahead of Tuesday's election.State and local officials have declined to do so, saying they have concerns with the accuracy of the federal government's list and fear that segregating the ballots could disenfranchise legitimate voters.
"We will not be intimidated by a sham investigation," he said.
This is a developing story and will be updated.
Leider, who previously clerked for Supreme Court Justice Clarence Thomas, is expected to return to his previous role as a law professor at George Mason University 's Antonin Scalia Law School, the ATF added.
The Justice Department has issued grand jury subpoenas to state and local officials in California, escalating a dispute over allegations by the federal government that the state may have as many as 20,000 non-citizens registered to vote ahead of the midterm elections, according to sources with direct knowledge and copies seen by CBS News.
Also by Sarah N. Lynch
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 40 articles by Sarah N. Lynch →

Topics

Abbott Labs CBS News DOJ False Claims Act the Justice Department

Subjects

the Justice Department ORG · 4× DOJ ORG · 3× Abbott Laboratories ORG · 2× Abbott Labs ORG · 2× CBS News ORG · 2× Michigan GPE · 2× Criminal Division ORG · 1× Stanley Woodward PERSON · 1× Tysen Duva PERSON · 1× the Justice Department's ORG · 1×

Narrative

The decision to pursue a civil settlement with Abbott Labs and close the parallel criminal case marks one example in a string of corporate cases involving public health and safety under the federal Food, Drug and Cosmetic Act that have been softened, dismissed or lost support from senior Justice Department leaders in recent months, CBS previously reported.
framing: mixed · carried by 1 article(s) · first seen 2026-09-14
Federal prosecutors originally tried to pursue felony charges and had the support of Tysen Duva, the assistant attorney general of the Justice Department's Criminal Division, but senior DOJ leadership would not allow the case to proceed.

Claims (14 extracted, 4 hedged)

Baby formula maker Abbott Laboratories agreed to pay nearly $385 million to resolve a civil False Claims Act case with the Justice Department and some states stemming from a Cronobacter bacterial contamination at one of its plants in Michigan that manufactures powdered baby formula, the department announced on Monday. uncertain
department → agree → Monday
Earlier this year, the Justice Department to close a parallel criminal investigation, CBS News previously reported. asserted
News → close → investigation
Federal prosecutors originally tried to pursue felony charges and had the support of Tysen Duva, the assistant attorney general of the Justice Department's Criminal Division, but senior DOJ leadership would not allow the case to proceed. asserted
case → try → Division
A senior DOJ official told CBS News in February that the department felt that a civil False Claims Act resolution was "the best mechanism to achieve accountability, deterrence and protection of the public" in the matter. uncertain
resolution → tell → matter
The civil False Claims Act case alleged that the company caused government programs to purchase powdered infant formula alleged by the government to have been made "in an environment that put the products at unacceptable risk of microorganism contamination and significantly impacted the products' reliability, quality, and safety. uncertain
that → allege → reliability
" "No company should be gambling on the health and safety of our nation's infants by allowing unsanitary conditions to persist at a facility manufacturing baby formula," said Associate Attorney General Stanley Woodward in a statement. asserted
Woodward → gamble → statement
The company said the settlement with the government "does not represent any finding of fault or liability," according to a statement. uncertain
settlement → say → statement
"As the government has previously indicated, it has closed its criminal investigation on this matter," the company said, adding that tests conducted by government regulators of unopened formula products from the homes of the infants under investigation at the time of the 2022 recall were negative for Cronobacter sakazakii. asserted
tests → indicate → sakazakii
The decision to pursue a civil settlement with Abbott Labs and close the parallel criminal case marks one example in a string of corporate cases involving public health and safety under the federal Food, Drug and Cosmetic Act that have been softened, dismissed or lost support from senior Justice Department leaders in recent months, CBS previously reported. asserted
CBS → pursue → months
Earlier this year, the Justice Department allowed Alibaba to enter into a nonprosecution agreement and pay $600 million, even though prosecutors on the case believed they had evidence the company was liable for felonies by failing to prevent dangerous drugs, chemicals and pill presses from being sold to American customers over an eight-year period. asserted
company → allow → period
"If prosecuting cases involving the risk of injuries or death to premature infants are not a priority enforcement matter, I have questions about what priorities the DOJ considers worthy of pursuing," Schiff wrote in a letter to Attorney General Todd Blanche. asserted
Schiff → prosecute → Blanche
In 2022, Abbott Laboratories several of its popular powdered formula brands, including Similac, after consumers complained about related to products from Abbott Nutrition, in Sturgis, Michigan. asserted
consumers → include → Sturgis
The Justice Department said the company had failed to take steps to fix roof leaks, resorting instead to "temporary solutions" that still left its products at risk for microorganism contamination. asserted
that → say → contamination
The department also said that the company "intentionally did not test for bacterial growth to avoid obtaining positive test results showing contamination" and that in some cases where testing showed evidence of micro contamination, it failed to disclose those results to the Food and Drug Administration during inspections in 2019 and 2022. asserted
it → say → 2019
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support